KRT8 Antikörper (N-Term)
Kurzübersicht für KRT8 Antikörper (N-Term) (ABIN631865)
Target
Alle KRT8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Cytokeratin 8 antibody was raised against the N terminal of KRT8
-
Aufreinigung
- Affinity purified
-
Immunogen
- Cytokeratin 8 antibody was raised using the N terminal of KRT8 corresponding to a region with amino acids MSIRVTQKSYKVSTSGPRAFSSRSYTSGPGSRISSSSFSRVGSSNFRGGL
-
-
-
-
Applikationshinweise
-
WB: 0.5 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
Cytokeratin 8 Blocking Peptide, (ABIN5613110), is also available for use as a blocking control in assays to test for specificity of this Cytokeratin 8 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of KRT8 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- KRT8 (Keratin 8 (KRT8))
-
Andere Bezeichnung
- Cytokeratin 8
-
Hintergrund
- KRT8 together with KRT19, help to link the contractile apparatus to dystrophin at the costameres of striated muscle.
-
Molekulargewicht
- 53 kDa (MW of target protein)
Target
-